Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Clinical trial NCT00508274 · TERMINATED

Trial details

NCT number: NCT00508274
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2007-07-18
Primary completion: 2015-12-02
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.